OncoQuébec is a platform that helps Quebecers find all the information in their research for clinical trials in oncology.

Classified as: Clinical trials, Cancer, Oncology
Category:
Published on: 16 Jan 2023

Professor Jonathan Kimmelman, Director of the Biomedical Ethics Unit is among the experts quoted by STAT.

Classified as: SPGH, BMEU, Jonathan Kimmelman, ethics, clinical research, Clinical trials
Published on: 21 Oct 2021

Company to run a Phase 2 clinical study with LAU-7b, a pro-resolving drug with potential antiviral properties against coronavirus

Classified as: anti-viral drugs, Clinical trials, press release, covid-19, therapies
Published on: 9 Apr 2020

 

By Jonathan Kimmelman, associate professor at McGill University and director of its Biomedical Ethics Unit, and Alex John London (Carnegie Mellon) 

There is a lot of money behind providing cancer care, and cancer treatment centers spend an estimated $173 million on advertising each year. One of the ways they compete for patients is by offering a menu of clinical trial options and suggesting that participating in such trials gives patients an edge on their care.

Classified as: bioethics, Clinical trials, mcgill medicine
Category:
Published on: 25 Apr 2018

Standards for authorizing first-time trials of drugs in humans are lax, and should be strengthened in several ways, McGill University researchers argue in a paper published today in Nature.

Classified as: ethics, nature, drug, Clinical trials, first-in-human, preclinical, Kimmelman, Federico, STREAM
Published on: 30 Jan 2017

Badly designed studies may lead to the efficacy of drugs being overestimated and money being wasted on trials that prove fruitless, according to a new study from McGill University in Canada.

Classified as: Research, animal research, mice, Clinical trials, drug trial, sunitinib, preclinical research, animal study, animal models, cancer drug, randomization, blinding, Jonathan Kimmelman, reproducibility, study design, guinea pig
Published on: 14 Oct 2015

A new study finds that rising placebo responses may play a part in the increasingly high failure rate for clinical trials of drugs designed to control chronic pain caused by nerve damage.

Classified as: drugs, pain, chronic pain, Jeffrey Mogil, Clinical trials, placebo, Alexander Tuttle, drug trials, pain killers
Category:
Published on: 6 Oct 2015
Back to top